Skip to the page

Data / Form D filings / Synthesis Health Inc.

Synthesis Health Inc.: Form D filings

Synthesis Health Inc., a health care company in Vancouver, British Columbia, Canada, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on August 5, 2026, reports $23.8 million sold of a $25.5 million offering to 79 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2900-500 BURRARD STREET, Vancouver, British Columbia, Canada, V6C 0
Phone
(832) 852-5815
Industry
Other Health Care
Entity type
Corporation
Incorporated in
British Columbia, Canada
Year incorporated
2021
Revenue range
$5,000,001 - $25,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2040850

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 5, 2026Amendment$25,547,445$23,780,483$1,766,96279Jul 25, 2025sec.gov
Aug 6, 2025New notice$14,594,279$1,829,431$12,764,84814Jul 25, 2025sec.gov
Nov 5, 2024New notice$14,386,000$9,519,842$4,866,15844May 10, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Murray A ReicherExecutive Officer, Director
Francois A Van HoutenExecutive Officer, DirectorChairman of the Board
Landon DownsDirector
William Michael BennettDirector
Deepak Roy KauraExecutive Officer
Joshua KaecheleExecutive Officer
Jeffrey NatlandDirector
Gupta RidhiExecutive Officer
Amy Scott GilchristExecutive Officer

Every Form D from the week of Aug 3, 2026 · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Synthesis Health Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.